Hazelden Betty Ford Foundation Appoints Four New Trustees to Enhance Addiction Treatment and Mental Health Services
ByAinvest
Thursday, Jul 31, 2025 10:08 am ET1min read
ADCT--
Patrick Denzer, president of LI Ventures, has extensive experience in investment and advisory roles, including leadership positions at TigerRisk and Guy Carpenter & Co. He is also actively involved with Hazelden Betty Ford through its National Center for Families and Children and Campaign Steering Committee [1].
Dr. Christopher Keir, vice president and global head of medical affairs at ADC Therapeutics, is a hematologist-oncologist with a background in leading medical affairs at EQRx, GRAIL, Array Biopharma, and Novartis. He earned his medical degree and a master's in biophysics and physiology from Georgetown University and completed his fellowship at Weill Cornell [1].
Dr. Monica Mayer is an emergency medicine physician and enrolled member of the Mandan Hidatsa Arikara nation. She is the first woman and physician to serve on the Mandan, Hidatsa and Arikara Nation Tribal Council. Dr. Mayer has a history of opening resource centers and supporting youth education, and she previously served as chief medical officer for the Indian Health Service's Great Plains Area [1].
Cini Robb is a long-time advocate for Hazelden Betty Ford's mission and returns to the Board of Trustees after serving from 2015 to 2024. She previously served on the Betty Ford Center Board and is president of the FACE Foundation and a member of the La Jolla Scripps Hospital Advisory Board [1].
These new trustees represent a diverse range of personal and professional experiences, including medicine, science, business, philanthropy, and public service. Their passion and expertise will help position Hazelden Betty Ford as a leader in evidence-based care, education, prevention, recovery support, and community engagement [1].
References:
[1] https://finance.yahoo.com/news/hazelden-betty-ford-foundation-appoints-130000771.html
[2] https://www.nasdaq.com/press-release/hazelden-betty-ford-foundation-appoints-four-new-members-its-board-trustees-2025-07
[3] https://www.barchart.com/story/news/33779445/hazelden-betty-ford-foundation-appoints-four-new-members-to-its-board-of-trustees
GRAL--
NVS--
PEG--
Hazelden Betty Ford Foundation has appointed four new members to its Board of Trustees: Patrick Denzer, Dr. Christopher Keir, Dr. Monica Mayer, and Cini Robb. Each trustee brings valuable experience and a strong commitment to advancing the organization's mission. Their insights and leadership will help elevate Hazelden Betty Ford as a leader in evidence-based care, education, prevention, recovery support, and community engagement.
Hazelden Betty Ford Foundation, a leading nonprofit in addiction treatment and mental health care, has appointed four accomplished professionals to its Board of Trustees: Patrick Denzer, Dr. Christopher Keir, Dr. Monica Mayer, and Cini Robb. These new trustees bring a wealth of experience and a strong commitment to advancing the organization's mission [1].Patrick Denzer, president of LI Ventures, has extensive experience in investment and advisory roles, including leadership positions at TigerRisk and Guy Carpenter & Co. He is also actively involved with Hazelden Betty Ford through its National Center for Families and Children and Campaign Steering Committee [1].
Dr. Christopher Keir, vice president and global head of medical affairs at ADC Therapeutics, is a hematologist-oncologist with a background in leading medical affairs at EQRx, GRAIL, Array Biopharma, and Novartis. He earned his medical degree and a master's in biophysics and physiology from Georgetown University and completed his fellowship at Weill Cornell [1].
Dr. Monica Mayer is an emergency medicine physician and enrolled member of the Mandan Hidatsa Arikara nation. She is the first woman and physician to serve on the Mandan, Hidatsa and Arikara Nation Tribal Council. Dr. Mayer has a history of opening resource centers and supporting youth education, and she previously served as chief medical officer for the Indian Health Service's Great Plains Area [1].
Cini Robb is a long-time advocate for Hazelden Betty Ford's mission and returns to the Board of Trustees after serving from 2015 to 2024. She previously served on the Betty Ford Center Board and is president of the FACE Foundation and a member of the La Jolla Scripps Hospital Advisory Board [1].
These new trustees represent a diverse range of personal and professional experiences, including medicine, science, business, philanthropy, and public service. Their passion and expertise will help position Hazelden Betty Ford as a leader in evidence-based care, education, prevention, recovery support, and community engagement [1].
References:
[1] https://finance.yahoo.com/news/hazelden-betty-ford-foundation-appoints-130000771.html
[2] https://www.nasdaq.com/press-release/hazelden-betty-ford-foundation-appoints-four-new-members-its-board-trustees-2025-07
[3] https://www.barchart.com/story/news/33779445/hazelden-betty-ford-foundation-appoints-four-new-members-to-its-board-of-trustees

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet